Page last updated: 2024-12-05

2-bromoethylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Bromoethylamine is a haloalkylamine, an organic compound with the formula BrCH2CH2NH2. It is a colorless liquid that is used as a reagent in organic synthesis. 2-Bromoethylamine is a versatile building block for the preparation of various nitrogen-containing compounds, including pharmaceuticals, agrochemicals, and polymers. It is known to react with various nucleophiles, such as amines, alcohols, and thiols, to form new C-N, C-O, and C-S bonds. The compound can be synthesized by reacting 2-bromoethanol with ammonia. 2-Bromoethylamine is also a precursor to the synthesis of other bromoalkylamines, which are used as alkylating agents. It is a potent alkylating agent and has been studied for its potential anticancer activity, but its toxicity limits its clinical use. It has been shown to have a variety of biological effects, including the inhibition of enzyme activity, the induction of DNA damage, and the disruption of cell signaling pathways. Further research is ongoing to explore its potential applications in medicine and other fields.'

Cross-References

ID SourceID
PubMed CID7851
CHEMBL ID1697693
SCHEMBL ID94211
MeSH IDM0045581

Synonyms (21)

Synonym
2-bromoethyl-amine
ethanamine, 2-bromo-
2-bromoethanamine
beta-bromoethylamine
einecs 203-461-8
brn 1098257
2-bromoethylamine ,
ethylamine, 2-bromo-
2-aminoethyl bromide
107-09-5
2-bromo-ethylamine
CHEMBL1697693
4-04-00-00458 (beilstein handbook reference)
STL223268
AKOS015858954
SCHEMBL94211
bromoethylamine
DTXSID8059346
.beta.-bromoethylamine
2-bromoethan-1-amine
EN300-35020

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" Renal injury was present 48 and 336 hr after BEA dosing based on increased renal organ weights, decreased urine specific gravity, and significant renal lesions (H & E)."( Magnetic resonance microscopy of toxic renal injury induced by bromoethylamine in rats.
Cofer, GP; Hedlund, LW; Johnson, GA; Maronpot, RR; Mills, GI; Wheeler, CT, 1991
)
0.28
" For the dose-response study, 150 male mice, 30 per group, were injected intraperitoneally (ip) with 100, 200, 300, 400 or 500 mg BEA/kg and ten from each group were killed 1, 3 or 5 days after treatment."( Acute cortical tubular necrosis in the Swiss ICR mouse induced by 2-bromoethylamine hydrobromide.
Carlton, WW; Wolf, DC, 1990
)
0.52
" Urine was collected for up to 48 hr after dosing and was analyzed by 1H NMR spectroscopy (400 MHz) and conventional biochemical methods to provide biochemical fingerprints of urine in various site-specific nephrotoxic states."( Investigations into the biochemical effects of region-specific nephrotoxins.
Bonner, FW; Gartland, KP; Nicholson, JK, 1989
)
0.28
" A specific V1, receptor AVP antagonist [d(CH2)5Tyr(Me)AVP] produced no fall in blood pressure but returned the noradrenaline dose-response curve to normal."( Selective renal medullary damage and hypertension in the rat: the role of vasopressin.
Bing, RF; Forsling, ML; Godfrey, NP; Russell, GI; Swales, JD; Thurston, H, 1986
)
0.27
"Renal papillary necrosis (RPN) was induced in Fischer 344 (F344) rats (n = 4) using 2-bromoethanamine hydrobromide (BEA) dosed at 150 mg/kg, and in multimammate desert mice (Mastomys natalensis) at 150 and 250 mg/kg (n = 4 per group)."( Comparative studies on the nephrotoxicity of 2-bromoethanamine hydrobromide in the Fischer 344 rat and the multimammate desert mouse (Mastomys natalensis).
Bonner, FW; Holmes, E; Nicholson, JK, 1995
)
0.29
" The changes ensued already after 1 wk of dosing and were first localized in the inner MCDs."( Serotonin (5-HT1A-receptor) agonist-induced collecting duct vacuolation and renal papillary necrosis in the rat.
Bomhard, EM; Hildebrand, H; Leser, KH; Loof, I; Rinke, M; Ruehl-Fehlert, C,
)
0.13
" Male Sprague-Dawley rats were dosed via intraperitoneal injection once daily for mercuric chloride and amphotericin (up to 7 doses), while a single dose was given for all other compounds."( Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers.
Afshari, CA; Bass, MB; Cosenza, ME; Fitzpatrick, VD; Galambos, E; Healy, L; Hu, R; Nordone, PJ; Sullivan, L; Thukral, SK, 2005
)
0.33
" 800 MHz (1)H spectra of human urine (n = 21) collected over 10 h following dosing with the antibiotic flucloxacillin and 600 MHz (1)H NMR spectra of rat urine (n = 27) collected over 48 h following exposure to the renal papillary toxin 2-bromoethanamine (BEA)."( Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery.
Coen, M; Ebbels, TM; Holmes, E; Lindon, JC; Maher, AD; Nicholson, JK; Sands, CJ, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1548203Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548204Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548205Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1548209Antibacterial activity against Escherichia coli K12 assessed as bacterial death up to 256 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID1548199Antibacterial activity against Staphylococcus aureus JE2 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548200Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548206Antifungal activity against Candida albicans ATCC 90028 assessed as fungal growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548207Antifungal activity against Cryptococcus neoformans var. grubii H99 ATCC 20882 assessed as fungal growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548201Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548202Antibacterial activity against Escherichia coli K12 assessed as bacterial growth inhibition at 32 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
AID1548208Antibacterial activity against Staphylococcus aureus JE2 assessed as bacterial death up to 256 ug/ml measured after 16 hrs by broth microdilution method2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (117)

TimeframeStudies, This Drug (%)All Drugs %
pre-199040 (34.19)18.7374
1990's37 (31.62)18.2507
2000's21 (17.95)29.6817
2010's17 (14.53)24.3611
2020's2 (1.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.35 (24.57)
Research Supply Index4.88 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index51.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.56%)5.53%
Reviews3 (2.34%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other123 (96.09%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]